Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oryzon Genomics SA ( (ES:ORY) ) has issued an update.
Oryzon Genomics SA has announced an Extraordinary General Meeting of Shareholders scheduled for February 28, 2025, to discuss proposed resolutions if the quorum is not met on the initial date. The meeting aims to engage shareholders in key decisions impacting the company’s future operations and strategies.
More about Oryzon Genomics SA
Oryzon Genomics SA operates in the biotechnology industry, focusing on developing innovative therapies and genomics-based solutions.
YTD Price Performance: -2.93%
Average Trading Volume: 4,869
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €93.64M
See more data about ORY stock on TipRanks’ Stock Analysis page.
